Survival Differences between Adolescent / Young Adults and Children with B-Precursor Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation

Risk adapted therapy has been the cornerstone of treatment for pediatric B-precursor acute lymphoblastic leukemia (B-ALL). Recently, age (>13 years at diagnosis) has been identified as a very high-risk feature for chemotherapy treated pediatric B-ALL patients. Whether age at time of transplant is...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Burke, Michael J., Gossai, Nathan, Wagner, John E., Smith, Angela R., Bachanova, Veronika, Cao, Qing, MacMillan, Margaret L., Stefanski, Heather S., Weisdorf, Daniel J., Verneris, Michael R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3530019/
https://ncbi.nlm.nih.gov/pubmed/22960388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.08.020
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller